CAD and cancer: Because CD8+ T-cell infiltration in TME is a well-established prognostic factor across various types of cancer, it may partly explain why patients with early-stage CRC showing high CPS expression have better survival benefits compared to their low CPS expression counterparts [59,60,61,62,63].